SYNDROME

More in SYNDROME

• 3/4th of AES-hit families fall below poverty line: Survey

  A social audit of families of children admitted with acute encephalitis syndrome (AES) conducted by the Bihar government reveals just how poor they are.

  

• Protests greet Nitish during Muzaffarpur hospital visit; AES toll climbs to 111

  Kumar, who was away in New Delhi since Saturday, had returned to Patna on Monday evening and held an emergency review meeting on the AES situation with officials. On Tuesday morning, the chief minister rushed to the Shri Krishna Medical College and Hospital (SKMCH) in Muzaffarpur, where more than 300 children have been admitted with complaints of AES since June 1 and close to 90 of them died.

  

• With the death of 4 more kids, encephalitis toll mounts to 47 in Bihar

  Despite a little dip in temperature due to light drizzle on Wednesday evening, no respite was seen to the hospital administration due to deaths of the innocent kids, inflicted with suspected acute encephalitis syndrome, as it has mounted to 47 on Thursday noon with deaths of four more kids at Sri Krishna Medical College and Hospital in last 24 hours.

  

• AI tool detects rare diseases from portraits, health data

  Every year, around half a million children worldwide are born with a rare hereditary disease. Obtaining a definitive diagnosis can be difficult and time consuming.

  

• Bihar: AES claims lives of three more kids at SKMCH

  Head of the SKMCH’s paediatrics department Dr Gopal Shankar Sahni said of the three victims, one was from Muzaffarpur and the two others from Sheohar and East Champaran districts.

  

• Lupin launches generic seizure drug in US

  As per IQVIA MAT March 2019 data, Clobazam tablets, in the two strengths, had an annual sales of around USD 479 million in the US, Lupin said.

  

• Pune: 15-year-old boy recovers from rare leg ailment after surgery

  City doctors treat him by replacing old arteries that were damaged due to heavy cycling

  

• 3 BP readings must for right diagnosis

  The chances of a patient’s blood pressure readings not being accurate are high if not taken thrice during a visit, states a new Indian study.

  

• Novo Nordisk and Gilead team up to test fatty liver disease treatment

  The clinical trial will be a study combining Novo Nordisk's semaglutide drug and Gilead's cilofexor and firsocostat for treatment of patients with Nonalcoholic steatohepatitis (NASH), Novo Nordisk, best known for its diabetes drugs, said on Friday.

  

• Puducherry: SBV, Medizones sign MoU to launch med device

  The device is unique in its nature as both the hot and the cold application can be given by the same device to make the eyes comfortable.

  

• Rest may be best medicine to treat some pains: Study

  In a study conducted in rats, researchers showed that a four-week period of rest was nearly as effective as an experimental drug at reducing discomfort and regaining function.